Scarica l'app Stockscreener
480.50
1.06%
-5.15
Dopo l'orario di chiusura:
480.00
-0.50
-0.10%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VRTX Giù?
Forum
Previsione
Frazionamento azionario
Vertex Pharmaceuticals Inc Borsa (VRTX) Ultime notizie
Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today - Yahoo Finance
Vertex Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Goldman Sachs Adjusts Price Target on Vertex Pharmaceuticals to $652 From $641, Maintains Buy Rating - Moomoo
Vertex Pharma stock trades near highs as cystic fibrosis portfolio drives double digit revenue growt - Ad-hoc-news.de
Vertex’s IgA nephropathy drug derisked after Novartis, Vera approvals - BioSpace
How FDA’s Pediatric Expansion of Casgevy at Vertex Pharmaceuticals (VRTX) Has Changed Its Investment Story - Yahoo Finance
Vertex Pharmaceuticals (VRTX) Wins FDA Nod To Treat Children As Young As 2 - Yahoo Finance Singapore
Vertex Pharmaceuticals just made a $10 billion acquisition worth watching - MSN
Vertex Pharmaceuticals Just Made a $10 Billion Acquisition Worth Watching - The Motley Fool
Latigo preps IPO to fund non-opioid rival to Vertex’s Journax - Fierce Biotech
Vertex Pharma stock steadies as cystic fibrosis franchise drives revenue and investors watch next da - ad-hoc-news.de
Vertex Pharmaceuticals (VRTX) Q1 2026 Earnings Call Transcript - Fortune
5 Best Biotech Stocks for 2026 and How to Invest - The Motley Fool
Parkinson’s in the Clinic, Insilico enters Phase III, Vertex Acquires Crinetics - genengnews.com
Vertex Pharma stock trades near record highs as cystic fibrosis franchise drives earnings momentum - Ad Hoc News
Vertex Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Lobbying Update: $1,200,000 of VERTEX PHARMACEUTICALS INCORPORATED lobbying was just disclosed - Quiver Quantitative
Is Vertex Pharmaceuticals Successfully Diversifying Beyond Cystic Fibrosis - Kavout | AI
Vertex Pharmaceuticals Inc Stock Price Live, Charts & News - The Economic Times
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance
Vertex Pharma stock steadies as analysts watch cystic fibrosis - ad-hoc-news.de
Vertex Pharmaceuticals (Ondo Tokenized) price today, VRTXON to USD live price, marketcap and chart - CoinDesk
Vertex Pharmaceuticals Currently Down Seven Consecutive Days, on Pace for Longest Losing Streak Since August 2021 -- Data Talk - Moomoo
Vertex Pharmaceuticals Stock 6-Day Losing Spree: Stock Falls 10% - Trefis
Vertex to Acquire Crinetics Pharmaceuticals (CRNX) in $85 Per Share Cash Deal - Yahoo Finance
Vertex Pharmaceuticals Stock Slides 10% Over 6 Straight Down Days - Trefis
Crinetics Pharmaceuticals (CRNX) Looks Fully Valued As Vertex Agrees $85 Per Share Deal - simplywall.st
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Calamos Advisors LLC - InsuranceNewsNet
Here's Why Vertex Was Willing to Pay a Premium of More Than 100% for Crinetics Pharmaceuticals - The Motley Fool
Analysts Conflicted on These Healthcare Names: Exelixis (EXEL) and Vertex Pharmaceuticals (VRTX) - The Globe and Mail
Vertex Pharmaceuticals (VRTX) Declines More Than Market: Some Information for Investors - Yahoo Finance
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy? - The Motley Fool
VRTX Maintained by UBS -- Price Target Raised to $585 - GuruFocus
Does Vertex's Acquisition of Crinetics Pharmaceuticals Make the Stock a No-Brainer Buy? - The Motley Fool
UBS Adjusts Vertex Pharmaceuticals Price Target to $585 From $545, Maintains Buy Rating - Moomoo
VRTX Maintained by Truist Securities -- Price Target Raised to $560 - GuruFocus
What to Expect From Vertex Pharmaceuticals' Next Quarterly Earnings Report - Yahoo Finance
Truist raises Vertex stock price target to $560 on Crinetics deal - Investing.com
Wells Fargo Maintains Vertex Pharmaceuticals(VRTX.US) With Buy Rating, Maintains Target Price $550 - Moomoo
Vertex Pharma stock holds steady as cystic fibrosis franchise underpins long-term growth outlook - ad-hoc-news.de
Drugmaker Vertex spends $10B to buy biotech firm to expand rare-disease offerings - Post and Courier
Vertex Pharmaceuticals (VRTX) Announces $10B Acquisition of Crin - GuruFocus
Vertex Pharmaceuticals (VRTX) Announces $10B Acquisition of Crinetics Pharmaceuticals - GuruFocus
The week in pharma: action, reaction and insight – week to July 10, 2026 - The Pharma Letter
Vertex (VRTX) Wins FDA Expansion For CASGEVY And Advances ALYFTREK In Canada - Yahoo Finance
Vertex Pharmaceuticals Bets $10 Billion on Crinetics to Build Endocrinology Powerhouse - TradingView
Biotech Stocks Face Big $15B Hit as Vertex, Ionis Skew Flat Weekly Tape - TechStock²
Is This Biotech Stock a Buy Near Its 52-Week High? - The Motley Fool
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Crinetics Pharmaceuticals (CRNX) sets 1-year executive non-competes tied to Vertex deal - Stock Titan
Why This Pharmaceutical Stock Jumped Close to 100% This Week - Yahoo Finance
Weekly Buzz: JNJ, VERA Get FDA Nod; VRTX Snaps Up CRNX; MSLE Aces DMD Trial; IONS Misses Key Goal - RTTNews
Nvidia, Vertex Pharmaceuticals And More On CNBC’s ‘Final Trades’ - Sahm
Rx Rundown: Vertex Pharmaceuticals, Real Chemistry, Vera Therapeutics and more - Medical Marketing and Media
A $10B deal, China trial scrutiny and highlights from ADA 2026 - Fierce Pharma
If You Invested $1000 in Vertex Pharmaceuticals a Decade Ago, This is How Much It'd Be Worth Now - Yahoo Finance
Vertex Pharmaceuticals Just Made a $10 Billion Move. Is the Stock a Buy? - The Motley Fool
0.67%
1.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):